Calvin Yu

Calvin Yu has a diverse work experience in the finance and accounting industry. Calvin is currently serving as the VP Accounting at Adverum Biotechnologies since January 2023. Previously, they held the position of Vice President, Finance at Alector from June 2017 to September 2022. Prior to that, they worked as the Corporate Controller at Stemcentrx, Inc. from February 2016 to June 2017. Calvin also held the role of Senior Director, Finance and SEC Reporting at Adverum Biotechnologies Inc from September 2014 to February 2016. Before their roles in biotechnology companies, they served as the Director, Controller at Five Prime Therapeutics from March 2010 to September 2014. Earlier in their career, they worked in roles of increasing responsibility at Proteolix, Cell Genesys, Ernst & Young, and Moss Adams LLP.

Calvin Yu earned a Bachelor of Science degree in Accounting from San Francisco State University, Lam Family College of Business, completing their education from 1996 to 2000.